Future Market Insights (FMI), presenting its most recent comprehensive analysis, forecasts that the global colorectal cancer molecular diagnostics market will expand at an 8% CAGR from its estimated US$ 2.35 billion in 2022 to US$ 5.07 billion by 2032. The market is expanding due to improvements in diagnostic labs and an increase in the incidence …